Hedge fund manager Mitchell J. Blutt of the $1.5 billion Consonance Capital fund has made some intriguing portfolio shifts in the last quarter, including boosting his position in biopharma firm Catalyst Pharmaceuticals (NASDAQ:CPRX) and initiating stakes in drug makers Verastem (NASDAQ:VSTM) and Sesen Bio (NYSE:SESN). Dr. Blutt is one of the first physicians to play a major role […]

Whatever their motivations, spin-offs can have a dramatic effect on the performance of the associated corporate bonds, so it is crucial that fixed-income investors conduct the necessary analysis. Nathan N.J. Grant, CFA, has some advice.

Russia has imposed the Caspian Convention it dictated, but vetoes Iran’s membership in the Euro-Asian “economic family” and the Shanghai Group. Russia’s interest is keeping Iran out of the international gas market, thus holding Moscow’s Damocles Sword